ArticlePeerJ2017
Whole genome sequencing of group A
Article in PeerJ, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 41 citations in OpenAlex.
- Molecular Characterization ofMicroorganisms · 2025Article
- Identifying genetic variations ineLife · 2025Article
- Increasing incidence of invasive group A streptococcal (iGAS) outbreaks in England 2015-2019.Epidemiology and infection · 2025Article
- Molecular characterization ofMicrobial genomics · 2024Article
- Rapid expansion and international spread of M1Nature communications · 2024Article
- Characterization of emergent toxigenic M1Microbial genomics · 2023Article
- Genomic Characterization of Skin and Soft Tissue Streptococcus pyogenes Isolates from a Low-Income and a High-Income Setting.mSphere · 2023Article
- A review of penicillin binding protein and group AFrontiers in cellular and infection microbiology · 2023Review
- Standardization of Epidemiological Surveillance of Group A Streptococcal ImpetigoOpen forum infectious diseases · 2022Article
- Standardization of Epidemiological Surveillance of Invasive Group A Streptococcal InfectionsOpen forum infectious diseases · 2022Article
- GBS-SBG - GBS Serotyping by Genome Sequencing.Microbial genomics · 2021Article
- Cryptic prophages within aMicrobial genomics · 2021Article
- Article
- Article
- Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study.The Lancet. Infectious diseases · 2019Article
- Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.Nature genetics · 2019Article
- A Controlled Human Infection Model of Group AmSphere · 2019Article
- Molecular Epidemiology, Ecology, and Evolution of Group A Streptococci.Microbiology spectrum · 2018Review
- PrevalentFrontiers in public health · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.